Noteworthy Tuesday Option Activity: BILL, ALAB, AFRM

Astera Labs (ALAB) saw 35,160 option contracts trade (~3.5M underlying shares), about 75.5% of its one‑month average daily volume (4.7M), with particularly heavy activity in the $162.50 put expiring Jan 23, 2026 (4,008 contracts, ~400,800 shares). Affirm Holdings (AFRM) recorded 34,824 option contracts (~3.5M underlying shares), ~72% of its one‑month ADTV (4.8M), led by the $90 call expiring Feb 20, 2026 (2,383 contracts, ~238,300 shares). The concentration in single strikes and large notional flow suggests notable short‑term positioning that could increase volatility and influence near‑term price moves in both names.

Analysis

Market structure: The outsized single‑strike activity (ALAB ~35,160 contracts → ~3.5M shares ≈75.5% ADTV; AFRM ~34,824 contracts → ~3.5M shares ≈72% ADTV) implies significant dealer delta hedging flows over coming days/weeks—if these are buys, market makers will buy AFRM shares and sell ALAB shares into the market, mechanically pressuring prices. That transient flow can move prices 5–15% intraday in low/medium liquidity names and may compress apparent bid/ask spreads while increasing implied volatility skew around the $162.50 (ALAB) and $90 (AFRM) strikes.

Risk assessment: Tail risk includes concentrated directional bets being wrong (large put/call blocks unwind → forced gamma reversals), regulatory shocks to fintech (AFRM) or supply-chain shocks to semiconductors (ALAB). Timewise, expect immediate (days) hedge-induced flow, short term (weeks–months) IV re-pricing into the expiries Jan/Feb 2026, and longer term (quarters) fundamental divergence driven by payment/credit cycles for AFRM and data-center capex for ALAB. Hidden dependencies: large block trades may be part of structured products, volatility monetization or client re-balancing—not pure directional bets.

Trade implications: Favor small, asymmetry-focused option structures rather than large outright equity bets. For AFRM, a bullish call spread captures upside driven by dealer buying while capping cost; for ALAB, a bear put spread or short equity hedge captures downside if puts are being bought. Monitor IV rank and flow: act when short‑term IV >30% and IV skew steepens by ≥5 pts relative to 3‑month IV to justify paid protection.

Contrarian angles: Consensus assumes directional intent; alternatively flows can be delta‑neutral (calendar/vol trades) and expiry pinning could create mean reversion after expiries. Reaction may be overdone: if ALAB put demand is hedge-driven, selling short immediately risks a squeeze once delta hedges are squared—consider staggered entry and using spreads. Historical parallels: large single‑strike blocks in 2021–22 often produced short-lived price moves then mean reversion within 30–60 days once hedges unwind.

Key Decisions for Investors

• Establish a tactical, size‑controlled pair: allocate 1% NAV long AFRM via Feb 20, 2026 $85/$95 call spread (buy $85, sell $95) to limit downside and capture upside from dealer delta buying; scale in up to 2% NAV if price breaks above $95 before expiry.
• Establish 0.5–1% NAV protection/short on ALAB: buy Jan 23, 2026 $162.50/$140 put spread (limit risk, widest strike depending on premium) or short 0.5% NAV outright equity if ALAB closes below $150 with rising volume; cut position if ALAB rallies above $175 or IV falls >8 pts.
• Run a relative value trade: long AFRM call spread (above) and fund with short ALAB put spread (sell higher‑premium near term) sized to be delta‑neutral; rebalance weekly and unwind 7–14 days before the Jan/Feb expiries to avoid pin risk.
• Risk controls & triggers: do not enter if IV rank <30 or if bid/ask wide >1.5% of premium; add only after confirming flow (options volume >50% of ADTV for 2 consecutive sessions) and set stop losses at 40% of premium paid or when underlying breaches 10% against position within 7 trading days.